Study of Surgical Removal vs. Radiation Therapy for Early Stage Lung Cancer

What we are studying

The purpose of this research study is to compare the effects (good and bad) of stereotactic body radiotherapy (SBRT - a type of radiation therapy) versus surgical removal of your lung cancer, to see which is better. This is an observational study. You may qualify to take part in this research study if you are currently being treated for stage IA non-small cell lung cancer using one of the above two methods.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Newly diagnosed with primary stage I Non-Small-Cell Lung Cancer
  • High risk for lobectomy (surgery)
  • Planned treatment with limited resection (surgery) OR SBRT (radiation therapy)
  • Not have had prior radiation treatment to the chest area
  • Speak English or Spanish
  • Not be severely cognitively impaired or have dementia
  • Have a telephone contact number
  • Be community dwelling

What is involved

  • In-Person interviews (questionnaires) at baseline; 6-months; and 12-months
  • Pulmonary lung function testing at baseline; 6-months; and 12-months
  • Phone interviews (questionnaires) at 7-day; 30-day; and 3-month follow-ups.


Compensation is up to $225 per subject, if all visits and interviews are completed. You will be paid either $50 (in-person interview) or $25 (phone interview) for the visits you complete.

Contact Information

Study Coordinator
Sharon Averill, RN, CRA
Principal Investigator
Marcelo Bonomi, M.D.

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.